Clinical Trials Browser

Phase 1/2 × Bronchiolitis Obliterans Syndrome × Rituximab × Clear all

Bronchiolitis Obliterans Syndrome, Leukemia, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous

NCT00379587 2014-03-19

Rituximab for Prevention of Chronic GVHD

Phase 1/2 Completed

65 enrolled 9 charts

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

Clinical Trials

Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL

Rituximab for Prevention of Chronic GVHD